scholarly article | Q13442814 |
P50 | author | Lauren O Bakaletz | Q78772868 |
P2093 | author name string | Glen McGillivary | |
Eric A Jones | |||
P2860 | cites work | Enteric defensins are essential regulators of intestinal microbial ecology | Q37483232 |
Different biofilms, different disease? A clinical outcomes study | Q37773865 | ||
Binding of Haemophilus influenzae to purified mucins from the human respiratory tract | Q39822372 | ||
Role of extracellular DNA in initial bacterial adhesion and surface aggregation | Q40527167 | ||
Transforming Growth Factor-β-Smad Signaling Pathway Negatively Regulates Nontypeable Haemophilus influenzae-induced MUC5AC Mucin Transcription via Mitogen-activated Protein Kinase (MAPK) Phosphatase-1-dependent Inhibition of p38 MAPK | Q40649602 | ||
Otitis media in children: frequency, risk factors, and research avenues | Q40749003 | ||
Distribution of bacterial proteins in biofilms formed by non-typeable Haemophilus influenzae | Q41626226 | ||
Activity of an antimicrobial peptide mimetic against planktonic and biofilm cultures of oral pathogens | Q41822185 | ||
Role of sialic acid and complex carbohydrate biosynthesis in biofilm formation by nontypeable Haemophilus influenzae in the chinchilla middle ear. | Q41836976 | ||
Biofilms formed by nontypeable Haemophilus influenzae in vivo contain both double-stranded DNA and type IV pilin protein | Q42011049 | ||
Nontypeable Haemophilus influenzae initiates formation of neutrophil extracellular traps | Q42165331 | ||
Identification and characterization of a mucosal antimicrobial peptide expressed by the chinchilla (Chinchilla lanigera) airway. | Q43639842 | ||
The antimicrobial activity of the cathelicidin LL37 is inhibited by F-actin bundles and restored by gelsolin | Q44296193 | ||
Overall cost in the treatment of otitis media | Q45103023 | ||
Measuring the indirect and direct costs of acute otitis media | Q45116242 | ||
Nontypeable Haemophilus influenzae lipoprotein P6 induces MUC5AC mucin transcription via TLR2-TAK1-dependent p38 MAPK-AP1 and IKKbeta-IkappaBalpha-NF-kappaB signaling pathways | Q46058384 | ||
Biofilms can be dispersed by focusing the immune system on a common family of bacterial nucleoid-associated proteins | Q46927233 | ||
Release of the antimicrobial peptide LL-37 from DNA/F-actin bundles in cystic fibrosis sputum. | Q51084969 | ||
Capsule polysaccharide is a bacterial decoy for antimicrobial peptides. | Q54413052 | ||
Multiple combination antibiotic susceptibility testing of nontypeable Haemophilus influenzae biofilms | Q59510334 | ||
The non-typeable Haemophilus influenzae Sap transporter provides a mechanism of antimicrobial peptide resistance and SapD-dependent potassium acquisition | Q79299836 | ||
Differential expression of human beta defensin 2 and human beta defensin 3 in human middle ear cholesteatoma | Q80123581 | ||
Hydrophobic interactions in complexes of antimicrobial peptides with bacterial polysaccharides | Q80505630 | ||
Abrogation of nontypeable Haemophilus influenzae protein D function reduces phosphorylcholine decoration, adherence to airway epithelial cells, and fitness in a chinchilla model of otitis media | Q82939703 | ||
Extracellular DNA chelates cations and induces antibiotic resistance in Pseudomonas aeruginosa biofilms | Q21090518 | ||
Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6 | Q22010648 | ||
Antimicrobial polypeptides in host defense of the respiratory tract | Q24551612 | ||
Biofilm formation by nontypeable Haemophilus influenzae: strain variability, outer membrane antigen expression and role of pili | Q24793297 | ||
Bacterial biofilms: a common cause of persistent infections | Q27861033 | ||
Defensins: antimicrobial peptides of innate immunity | Q28204453 | ||
The biofilm matrix | Q29547334 | ||
Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide | Q29619485 | ||
Compared to placebo, long-term antibiotics resolve otitis media with effusion (OME) and prevent acute otitis media with perforation (AOMwiP) in a high-risk population: a randomized controlled trial | Q30482567 | ||
Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media | Q33249853 | ||
A mutation in the sap operon attenuates survival of nontypeable Haemophilus influenzae in a chinchilla model of otitis media | Q33557688 | ||
Differential and coordinated expression of defensins and cytokines by gingival epithelial cells and dendritic cells in response to oral bacteria | Q33629441 | ||
Demonstration of Type IV pilus expression and a twitching phenotype by Haemophilus influenzae | Q33716078 | ||
The multifunctional host defense peptide SPLUNC1 is critical for homeostasis of the mammalian upper airway | Q33719376 | ||
Pilus-mediated adherence of Haemophilus influenzae to human respiratory mucins | Q34004701 | ||
Nontypeable Haemophilus influenzae: pathogenesis and prevention | Q34009998 | ||
Dying for a cause: NETosis, mechanisms behind an antimicrobial cell death modality | Q34162570 | ||
The human beta-defensin-3, an antibacterial peptide with multiple biological functions | Q34566449 | ||
Escherichia coli competence gene homologs are essential for competitive fitness and the use of DNA as a nutrient | Q34697000 | ||
Heme utilization by nontypeable Haemophilus influenzae is essential and dependent on Sap transporter function | Q35096143 | ||
Cryptococcus neoformans cells in biofilms are less susceptible than planktonic cells to antimicrobial molecules produced by the innate immune system | Q35217511 | ||
Haemophilus influenzae infections in the H. influenzae type b conjugate vaccine era. | Q35530691 | ||
Quorum sensing and DNA release in bacterial biofilms | Q36418307 | ||
Production of beta-defensins by human airway epithelia | Q36758628 | ||
Nontypeable Haemophilus influenzae: understanding virulence and commensal behavior | Q36864761 | ||
Evidence behind the WHO guidelines: hospital care for children: what is the most effective antibiotic regime for chronic suppurative otitis media in children? | Q37178849 | ||
Salivary mucins inhibit antibacterial activity of the cathelicidin-derived LL-37 peptide but not the cationic steroid CSA-13. | Q37324151 | ||
Respiratory syncytial virus-induced dysregulation of expression of a mucosal beta-defensin augments colonization of the upper airway by non-typeable Haemophilus influenzae | Q37340656 | ||
P433 | issue | 1 | |
P921 | main subject | biofilm | Q467410 |
Haemophilus influenzae | Q1141979 | ||
P304 | page(s) | 24-38 | |
P577 | publication date | 2012-08-22 | |
P1433 | published in | Journal of Innate Immunity | Q15817533 |
P1476 | title | Extracellular DNA within a nontypeable Haemophilus influenzae-induced biofilm binds human beta defensin-3 and reduces its antimicrobial activity | |
P478 | volume | 5 |
Q57983426 | A Farewell to Arms: Streptococcal Strategies to Cope with Innate Immunity |
Q42147323 | A novel intrinsically disordered outer membrane lipoprotein of Aggregatibacter actinomycetemcomitans binds various cytokines and plays a role in biofilm response to interleukin-1β and interleukin-8. |
Q35579952 | Antibodies against the majority subunit of type IV Pili disperse nontypeable Haemophilus influenzae biofilms in a LuxS-dependent manner and confer therapeutic resolution of experimental otitis media |
Q36260636 | Bacterial Lysis through Interference with Peptidoglycan Synthesis Increases Biofilm Formation by Nontypeable Haemophilus influenzae |
Q36055572 | Candidacidal Activity of Selected Ceragenins and Human Cathelicidin LL-37 in Experimental Settings Mimicking Infection Sites. |
Q49631381 | Combination Strategies to Enhance the Efficacy of Antimicrobial Peptides against Bacterial Biofilms |
Q35175045 | Copy number variation of the beta defensin gene cluster on chromosome 8p influences the bacterial microbiota within the nasopharynx of otitis-prone children |
Q58725940 | Epigenetic Regulation Alters Biofilm Architecture and Composition in Multiple Clinical Isolates of Nontypeable Haemophilus influenzae |
Q42872458 | Evaluation of the kinetics and mechanism of action of anti-integration host factor-mediated disruption of bacterial biofilms |
Q47138997 | Extracellular DNA and Type IV Pilus Expression Regulate the Structure and Kinetics of Biofilm Formation by Nontypeable Haemophilus influenzae |
Q41002332 | Extracellular DNA facilitates the formation of functional amyloids in Staphylococcus aureus biofilms. |
Q92860794 | Extracellular DNA traps in inflammation, injury and healing |
Q92252424 | High concentrations of middle ear antimicrobial peptides and proteins and proinflammatory cytokines are associated with detection of middle ear pathogens in children with recurrent acute otitis media |
Q41193264 | Host Antimicrobial Peptides in Bacterial Homeostasis and Pathogenesis of Disease |
Q38923632 | Host-pathogen interactions of nontypeable Haemophilus influenzae: from commensal to pathogen |
Q35624139 | In vitro biofilm development of Streptococcus pneumoniae and formation of choline-binding protein-DNA complexes |
Q40235118 | Insights on persistent airway infection by non-typeable Haemophilus influenzae in chronic obstructive pulmonary disease |
Q41433550 | Nontypeable Haemophilus influenzae releases DNA and DNABII proteins via a T4SS-like complex and ComE of the type IV pilus machinery |
Q33851484 | Panel 4: Report of the Microbiology Panel |
Q36333073 | Panel 5: Immunology |
Q33563964 | Polyelectrolyte properties of filamentous biopolymers and their consequences in biological fluids |
Q35585523 | Prevention of biofilm formation and removal of existing biofilms by extracellular DNases of Campylobacter jejuni |
Q35027403 | Role of innate immunity in the pathogenesis of otitis media |
Q31121428 | Structural stability of Burkholderia cenocepacia biofilms is reliant on eDNA structure and presence of a bacterial nucleic acid binding protein |
Q26747423 | Sub-Optimal Treatment of Bacterial Biofilms |
Q91918184 | Subversion of host immune responses by otopathogens during otitis media |
Q47637669 | Targeting microbial biofilms: current and prospective therapeutic strategies. |
Q92283282 | The mechanism of action of pepR, a viral-derived peptide, against Staphylococcus aureus biofilms |
Q38168547 | The role of extracellular DNA in the establishment, maintenance and perpetuation of bacterial biofilms |
Q26997004 | Treatment of microbial biofilms in the post-antibiotic era: prophylactic and therapeutic use of antimicrobial peptides and their design by bioinformatics tools |
Q40728738 | Type IV Pilus Expression Is Upregulated in Nontypeable Haemophilus influenzae Biofilms Formed at the Temperature of the Human Nasopharynx |
Q37066508 | What's on the Outside Matters: The Role of the Extracellular Polymeric Substance of Gram-negative Biofilms in Evading Host Immunity and as a Target for Therapeutic Intervention |
Search more.